Grupo Ferrer grants Medimetriks exclusive commercial rights to ozenoxacin 1% for impetigo in the U.S., Puerto Rico and the U.S. Virgin Islands

Grupo Ferrer Internacional S.A.

Spain / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Medimetriks Pharmaceuticals Inc.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced